GENESIS Trial: Almost Ninety Percent of Multiple Myeloma Patients Were Able to Proceed to Transplantation

A recent article in Cancer Network announced that motixafortide met its primary endpoint in the GENESIS trial for multiple myeloma patients who were scheduled for stem cell transplantation. Often, the…

Continue Reading GENESIS Trial: Almost Ninety Percent of Multiple Myeloma Patients Were Able to Proceed to Transplantation
Study of the Week: Nucala’s Effectiveness in EGPA Confirmed in Real-World Study
source: pixabay.com

Study of the Week: Nucala’s Effectiveness in EGPA Confirmed in Real-World Study

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Nucala’s Effectiveness in EGPA Confirmed in Real-World Study
Ursodeoxycholic Acid Improves Outcomes of Intrahepatic Cholestasis of Pregnancy
source: pixabay.com

Ursodeoxycholic Acid Improves Outcomes of Intrahepatic Cholestasis of Pregnancy

According to MedPage Today, ursodeoxycholic acid significantly improves patient outcomes in relation to intrahepatic cholestasis of pregnancy. This rare liver disorder increases the risk of fetal issues, stillbirths, or preterm…

Continue Reading Ursodeoxycholic Acid Improves Outcomes of Intrahepatic Cholestasis of Pregnancy

Phase 3 Study for Primary Axillary Hyperhidrosis Has Demonstrated Positive Results

Brickell Biotech has just announced the findings from their Phase 3 study investigating the long-term efficacy and safety of sofpironium bromide gel for the treatment of primary axillary hyperhidrosis. Hyperhidrosis…

Continue Reading Phase 3 Study for Primary Axillary Hyperhidrosis Has Demonstrated Positive Results

Phase 2 Trial Shows Therapy Reduces Seizures in Dravet Syndrome and Lennox-Gastaut Syndrome

The American Academy of Neurology recently held their annual meeting virtually to discuss the latest research in Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS). This meeting was held April 17th through 22nd,…

Continue Reading Phase 2 Trial Shows Therapy Reduces Seizures in Dravet Syndrome and Lennox-Gastaut Syndrome

Light Therapy: A Safe, Effective, and Low-Cost Approach to Some Neurodegenerative Diseases

In the last decade, scientists have made great strides in uncovering details of the underlying causes of neurodegenerative diseases. It is only a matter of time that treatment and prevention…

Continue Reading Light Therapy: A Safe, Effective, and Low-Cost Approach to Some Neurodegenerative Diseases

Study Illuminates Treatment Options for Different Pediatric Adrenocortical Carcinoma Stages

A study published in the Journal of Clinical Oncology has detailed the benefits of different forms of treatment for pediatric patients with adrenocortical carcinoma. These researchers particularly looked at what treatments…

Continue Reading Study Illuminates Treatment Options for Different Pediatric Adrenocortical Carcinoma Stages